The global Oncology API market was valued at US$ 32850 million in 2025 and is anticipated to reach US$ 52740 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

Oncology API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oncology API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Oncology API (Active Pharmaceutical Ingredient) refers to the active substances used in the formulation of drugs specifically for the treatment of cancer. These APIs are used to target and treat various types of cancer through different mechanisms of action. They include chemotherapy agents, targeted therapies, hormonal treatments, and immunotherapies, each with specific mechanisms of action. The development, manufacturing, and regulatory oversight of these APIs are critical to ensuring their safety, efficacy, and availability for cancer patients.

In 2024, the global production of oncology APIs will exceed 50,000 tons, with an average selling price of US$659,000 per ton.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Oncology API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology API. The Oncology API market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oncology API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oncology API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Oncology API Market Report

Report Metric	Details
Report Name	Oncology API Market
Accounted market size in 2025	US$ 32850 million
Forecasted market size in 2032	US$ 52740 million
CAGR	7.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Alkylating Agents Antimetabolites Others
by Application	Chemotherapy Targeted Therapy Immunotherapy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, Dr. Reddy’s Laboratories, Cipla, Hetero, Johnson Matthey, Glenmark Life Sciences, Fresenius Kabi, Sterling, Mac-Chem, Biocon, Olon, Shivalik Rasayan, Concord Biotech, Kekulepharma, Aenova, Sarv Biolabs, Aspen, Suanfarma, Bachem, Piramal Pharma, Aurisco Pharmaceutical, Shilpa Medicare, Qilu Pharmaceutial, Hengrui, Hisun, Zhejiang Xianju Junye Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Oncology API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Oncology API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Oncology API Market growing?

Ans: The Oncology API Market witnessing a CAGR of 7.1% during the forecast period 2026-2032.

What is the Oncology API Market size in 2032?

Ans: The Oncology API Market size in 2032 will be US$ 52740 million.

Who are the main players in the Oncology API Market report?

Ans: The main players in the Oncology API Market are Teva Pharmaceutical, Dr. Reddy’s Laboratories, Cipla, Hetero, Johnson Matthey, Glenmark Life Sciences, Fresenius Kabi, Sterling, Mac-Chem, Biocon, Olon, Shivalik Rasayan, Concord Biotech, Kekulepharma, Aenova, Sarv Biolabs, Aspen, Suanfarma, Bachem, Piramal Pharma, Aurisco Pharmaceutical, Shilpa Medicare, Qilu Pharmaceutial, Hengrui, Hisun, Zhejiang Xianju Junye Pharmaceutical

What are the Application segmentation covered in the Oncology API Market report?

Ans: The Applications covered in the Oncology API Market report are Chemotherapy, Targeted Therapy, Immunotherapy, Others

What are the Type segmentation covered in the Oncology API Market report?

Ans: The Types covered in the Oncology API Market report are Alkylating Agents, Antimetabolites, Others

1 Oncology API Market Overview

1.1 Product Definition

1.2 Oncology API by Type

1.2.1 Global Oncology API Market Value by Type: 2025 vs 2032

1.2.2 Alkylating Agents

1.2.3 Antimetabolites

1.2.4 Others

1.3 Oncology API by Application

1.3.1 Global Oncology API Market Value by Application: 2025 vs 2032

1.3.2 Chemotherapy

1.3.3 Targeted Therapy

1.3.4 Immunotherapy

1.3.5 Others

1.4 Global Oncology API Market Size Estimates and Forecasts

1.4.1 Global Oncology API Revenue 2021–2032

1.4.2 Global Oncology API Sales 2021–2032

1.4.3 Global Oncology API Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Oncology API Market Competition by Manufacturers

2.1 Global Oncology API Sales Market Share by Manufacturers (2021–2026)

2.2 Global Oncology API Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Oncology API Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Oncology API, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Oncology API, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Oncology API, Product Types and Applications

2.7 Global Key Manufacturers of Oncology API, Date of Entry into the Industry

2.8 Global Oncology API Market Competitive Situation and Trends

2.8.1 Global Oncology API Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Oncology API Players Market Share by Revenue

2.8.3 Global Oncology API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oncology API Market Scenario by Region

3.1 Global Oncology API Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Oncology API Sales by Region: 2021–2032

3.2.1 Global Oncology API Sales by Region: 2021–2026

3.2.2 Global Oncology API Sales by Region: 2027–2032

3.3 Global Oncology API Revenue by Region: 2021–2032

3.3.1 Global Oncology API Revenue by Region: 2021–2026

3.3.2 Global Oncology API Revenue by Region: 2027–2032

3.4 North America Oncology API Market Facts & Figures by Country

3.4.1 North America Oncology API Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Oncology API Sales by Country (2021–2032)

3.4.3 North America Oncology API Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oncology API Market Facts & Figures by Country

3.5.1 Europe Oncology API Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Oncology API Sales by Country (2021–2032)

3.5.3 Europe Oncology API Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oncology API Market Facts & Figures by Region

3.6.1 Asia Pacific Oncology API Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Oncology API Sales by Region (2021–2032)

3.6.3 Asia Pacific Oncology API Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oncology API Market Facts & Figures by Country

3.7.1 Latin America Oncology API Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Oncology API Sales by Country (2021–2032)

3.7.3 Latin America Oncology API Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Oncology API Market Facts & Figures by Country

3.8.1 Middle East and Africa Oncology API Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Oncology API Sales by Country (2021–2032)

3.8.3 Middle East and Africa Oncology API Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oncology API Sales by Type (2021–2032)

4.1.1 Global Oncology API Sales by Type (2021–2026)

4.1.2 Global Oncology API Sales by Type (2027–2032)

4.1.3 Global Oncology API Sales Market Share by Type (2021–2032)

4.2 Global Oncology API Revenue by Type (2021–2032)

4.2.1 Global Oncology API Revenue by Type (2021–2026)

4.2.2 Global Oncology API Revenue by Type (2027–2032)

4.2.3 Global Oncology API Revenue Market Share by Type (2021–2032)

4.3 Global Oncology API Price by Type (2021–2032)

5 Segment by Application

5.1 Global Oncology API Sales by Application (2021–2032)

5.1.1 Global Oncology API Sales by Application (2021–2026)

5.1.2 Global Oncology API Sales by Application (2027–2032)

5.1.3 Global Oncology API Sales Market Share by Application (2021–2032)

5.2 Global Oncology API Revenue by Application (2021–2032)

5.2.1 Global Oncology API Revenue by Application (2021–2026)

5.2.2 Global Oncology API Revenue by Application (2027–2032)

5.2.3 Global Oncology API Revenue Market Share by Application (2021–2032)

5.3 Global Oncology API Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Company Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Teva Pharmaceutical Oncology API Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 Dr. Reddy’s Laboratories

6.2.1 Dr. Reddy’s Laboratories Company Information

6.2.2 Dr. Reddy’s Laboratories Description and Business Overview

6.2.3 Dr. Reddy’s Laboratories Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Dr. Reddy’s Laboratories Oncology API Product Portfolio

6.2.5 Dr. Reddy’s Laboratories Recent Developments/Updates

6.3 Cipla

6.3.1 Cipla Company Information

6.3.2 Cipla Description and Business Overview

6.3.3 Cipla Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Cipla Oncology API Product Portfolio

6.3.5 Cipla Recent Developments/Updates

6.4 Hetero

6.4.1 Hetero Company Information

6.4.2 Hetero Description and Business Overview

6.4.3 Hetero Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Hetero Oncology API Product Portfolio

6.4.5 Hetero Recent Developments/Updates

6.5 Johnson Matthey

6.5.1 Johnson Matthey Company Information

6.5.2 Johnson Matthey Description and Business Overview

6.5.3 Johnson Matthey Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Johnson Matthey Oncology API Product Portfolio

6.5.5 Johnson Matthey Recent Developments/Updates

6.6 Glenmark Life Sciences

6.6.1 Glenmark Life Sciences Company Information

6.6.2 Glenmark Life Sciences Description and Business Overview

6.6.3 Glenmark Life Sciences Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Glenmark Life Sciences Oncology API Product Portfolio

6.6.5 Glenmark Life Sciences Recent Developments/Updates

6.7 Fresenius Kabi

6.7.1 Fresenius Kabi Company Information

6.7.2 Fresenius Kabi Description and Business Overview

6.7.3 Fresenius Kabi Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Fresenius Kabi Oncology API Product Portfolio

6.7.5 Fresenius Kabi Recent Developments/Updates

6.8 Sterling

6.8.1 Sterling Company Information

6.8.2 Sterling Description and Business Overview

6.8.3 Sterling Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Sterling Oncology API Product Portfolio

6.8.5 Sterling Recent Developments/Updates

6.9 Mac-Chem

6.9.1 Mac-Chem Company Information

6.9.2 Mac-Chem Description and Business Overview

6.9.3 Mac-Chem Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Mac-Chem Oncology API Product Portfolio

6.9.5 Mac-Chem Recent Developments/Updates

6.10 Biocon

6.10.1 Biocon Company Information

6.10.2 Biocon Description and Business Overview

6.10.3 Biocon Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Biocon Oncology API Product Portfolio

6.10.5 Biocon Recent Developments/Updates

6.11 Olon

6.11.1 Olon Company Information

6.11.2 Olon Description and Business Overview

6.11.3 Olon Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Olon Oncology API Product Portfolio

6.11.5 Olon Recent Developments/Updates

6.12 Shivalik Rasayan

6.12.1 Shivalik Rasayan Company Information

6.12.2 Shivalik Rasayan Description and Business Overview

6.12.3 Shivalik Rasayan Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Shivalik Rasayan Oncology API Product Portfolio

6.12.5 Shivalik Rasayan Recent Developments/Updates

6.13 Concord Biotech

6.13.1 Concord Biotech Company Information

6.13.2 Concord Biotech Description and Business Overview

6.13.3 Concord Biotech Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Concord Biotech Oncology API Product Portfolio

6.13.5 Concord Biotech Recent Developments/Updates

6.14 Kekulepharma

6.14.1 Kekulepharma Company Information

6.14.2 Kekulepharma Description and Business Overview

6.14.3 Kekulepharma Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Kekulepharma Oncology API Product Portfolio

6.14.5 Kekulepharma Recent Developments/Updates

6.15 Aenova

6.15.1 Aenova Company Information

6.15.2 Aenova Description and Business Overview

6.15.3 Aenova Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Aenova Oncology API Product Portfolio

6.15.5 Aenova Recent Developments/Updates

6.16 Sarv Biolabs

6.16.1 Sarv Biolabs Company Information

6.16.2 Sarv Biolabs Description and Business Overview

6.16.3 Sarv Biolabs Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Sarv Biolabs Oncology API Product Portfolio

6.16.5 Sarv Biolabs Recent Developments/Updates

6.17 Aspen

6.17.1 Aspen Company Information

6.17.2 Aspen Description and Business Overview

6.17.3 Aspen Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Aspen Oncology API Product Portfolio

6.17.5 Aspen Recent Developments/Updates

6.18 Suanfarma

6.18.1 Suanfarma Company Information

6.18.2 Suanfarma Description and Business Overview

6.18.3 Suanfarma Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.18.4 Suanfarma Oncology API Product Portfolio

6.18.5 Suanfarma Recent Developments/Updates

6.19 Bachem

6.19.1 Bachem Company Information

6.19.2 Bachem Description and Business Overview

6.19.3 Bachem Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.19.4 Bachem Oncology API Product Portfolio

6.19.5 Bachem Recent Developments/Updates

6.20 Piramal Pharma

6.20.1 Piramal Pharma Company Information

6.20.2 Piramal Pharma Description and Business Overview

6.20.3 Piramal Pharma Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.20.4 Piramal Pharma Oncology API Product Portfolio

6.20.5 Piramal Pharma Recent Developments/Updates

6.21 Aurisco Pharmaceutical

6.21.1 Aurisco Pharmaceutical Company Information

6.21.2 Aurisco Pharmaceutical Description and Business Overview

6.21.3 Aurisco Pharmaceutical Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.21.4 Aurisco Pharmaceutical Oncology API Product Portfolio

6.21.5 Aurisco Pharmaceutical Recent Developments/Updates

6.22 Shilpa Medicare

6.22.1 Shilpa Medicare Company Information

6.22.2 Shilpa Medicare Description and Business Overview

6.22.3 Shilpa Medicare Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.22.4 Shilpa Medicare Oncology API Product Portfolio

6.22.5 Shilpa Medicare Recent Developments/Updates

6.23 Qilu Pharmaceutial

6.23.1 Qilu Pharmaceutial Company Information

6.23.2 Qilu Pharmaceutial Description and Business Overview

6.23.3 Qilu Pharmaceutial Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.23.4 Qilu Pharmaceutial Oncology API Product Portfolio

6.23.5 Qilu Pharmaceutial Recent Developments/Updates

6.24 Hengrui

6.24.1 Hengrui Company Information

6.24.2 Hengrui Description and Business Overview

6.24.3 Hengrui Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.24.4 Hengrui Oncology API Product Portfolio

6.24.5 Hengrui Recent Developments/Updates

6.25 Hisun

6.25.1 Hisun Company Information

6.25.2 Hisun Description and Business Overview

6.25.3 Hisun Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.25.4 Hisun Oncology API Product Portfolio

6.25.5 Hisun Recent Developments/Updates

6.26 Zhejiang Xianju Junye Pharmaceutical

6.26.1 Zhejiang Xianju Junye Pharmaceutical Company Information

6.26.2 Zhejiang Xianju Junye Pharmaceutical Description and Business Overview

6.26.3 Zhejiang Xianju Junye Pharmaceutical Oncology API Sales, Revenue, and Gross Margin (2021–2026)

6.26.4 Zhejiang Xianju Junye Pharmaceutical Oncology API Product Portfolio

6.26.5 Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oncology API Industry Chain Analysis

7.2 Oncology API Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oncology API Production Mode & Process Analysis

7.4 Oncology API Sales and Marketing

7.4.1 Oncology API Sales Channels

7.4.2 Oncology API Distributors

7.5 Oncology API Customer Analysis

8 Oncology API Market Dynamics

8.1 Oncology API Industry Trends

8.2 Oncology API Market Drivers

8.3 Oncology API Market Challenges

8.4 Oncology API Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Glenmark Life Sciences

Sterling

Concord Biotech

Biocon Ltd.

Shivalik Rasayan

Aenova

Suanfarma

Hetero

Bachem

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Aurisco Pharmaceutical

Zhejiang Xianju Junye Pharmaceutical

Kekulepharma

Sarv Biolabs

List of Tables

Table 1. Global Oncology API Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Oncology API Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Oncology API Market Competitive Situation by Manufacturers in 2025

Table 4. Global Oncology API Sales (kg) of Key Manufacturers (2021–2026)

Table 5. Global Oncology API Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Oncology API Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Oncology API Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Oncology API Average Price (US$/kg) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Oncology API, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Oncology API, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Oncology API, Product Types and Applications

Table 12. Global Key Manufacturers of Oncology API, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oncology API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oncology API Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oncology API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Oncology API Sales by Region (kg), 2021–2026

Table 18. Global Oncology API Sales Market Share by Region (2021–2026)

Table 19. Global Oncology API Sales by Region (kg), 2027–2032

Table 20. Global Oncology API Sales Market Share by Region (2027–2032)

Table 21. Global Oncology API Revenue by Region (US$ Million), 2021–2026

Table 22. Global Oncology API Revenue Market Share by Region (2021–2026)

Table 23. Global Oncology API Revenue by Region (US$ Million), 2027–2032

Table 24. Global Oncology API Revenue Market Share by Region (2027–2032)

Table 25. North America Oncology API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Oncology API Sales by Country (kg), 2021–2026

Table 27. North America Oncology API Sales by Country (kg), 2027–2032

Table 28. North America Oncology API Revenue by Country (US$ Million), 2021–2026

Table 29. North America Oncology API Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Oncology API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Oncology API Sales by Country (kg), 2021–2026

Table 32. Europe Oncology API Sales by Country (kg), 2027–2032

Table 33. Europe Oncology API Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Oncology API Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Oncology API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Oncology API Sales by Region (kg), 2021–2026

Table 37. Asia Pacific Oncology API Sales by Region (kg), 2027–2032

Table 38. Asia Pacific Oncology API Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Oncology API Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Oncology API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Oncology API Sales by Country (kg), 2021–2026

Table 42. Latin America Oncology API Sales by Country (kg), 2027–2032

Table 43. Latin America Oncology API Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Oncology API Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Oncology API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Oncology API Sales by Country (kg), 2021–2026

Table 47. Middle East and Africa Oncology API Sales by Country (kg), 2027–2032

Table 48. Middle East and Africa Oncology API Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Oncology API Revenue by Country (US$ Million), 2027–2032

Table 50. Global Oncology API Sales (kg) by Type (2021–2026)

Table 51. Global Oncology API Sales (kg) by Type (2027–2032)

Table 52. Global Oncology API Sales Market Share by Type (2021–2026)

Table 53. Global Oncology API Sales Market Share by Type (2027–2032)

Table 54. Global Oncology API Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Oncology API Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Oncology API Revenue Market Share by Type (2021–2026)

Table 57. Global Oncology API Revenue Market Share by Type (2027–2032)

Table 58. Global Oncology API Price (US$/kg) by Type (2021–2026)

Table 59. Global Oncology API Price (US$/kg) by Type (2027–2032)

Table 60. Global Oncology API Sales (kg) by Application (2021–2026)

Table 61. Global Oncology API Sales (kg) by Application (2027–2032)

Table 62. Global Oncology API Sales Market Share by Application (2021–2026)

Table 63. Global Oncology API Sales Market Share by Application (2027–2032)

Table 64. Global Oncology API Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Oncology API Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Oncology API Revenue Market Share by Application (2021–2026)

Table 67. Global Oncology API Revenue Market Share by Application (2027–2032)

Table 68. Global Oncology API Price (US$/kg) by Application (2021–2026)

Table 69. Global Oncology API Price (US$/kg) by Application (2027–2032)

Table 70. Teva Pharmaceutical Company Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 73. Teva Pharmaceutical Oncology API Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. Dr. Reddy’s Laboratories Company Information

Table 76. Dr. Reddy’s Laboratories Description and Business Overview

Table 77. Dr. Reddy’s Laboratories Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 78. Dr. Reddy’s Laboratories Oncology API Product

Table 79. Dr. Reddy’s Laboratories Recent Developments/Updates

Table 80. Cipla Company Information

Table 81. Cipla Description and Business Overview

Table 82. Cipla Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 83. Cipla Oncology API Product

Table 84. Cipla Recent Developments/Updates

Table 85. Hetero Company Information

Table 86. Hetero Description and Business Overview

Table 87. Hetero Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 88. Hetero Oncology API Product

Table 89. Hetero Recent Developments/Updates

Table 90. Johnson Matthey Company Information

Table 91. Johnson Matthey Description and Business Overview

Table 92. Johnson Matthey Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 93. Johnson Matthey Oncology API Product

Table 94. Johnson Matthey Recent Developments/Updates

Table 95. Glenmark Life Sciences Company Information

Table 96. Glenmark Life Sciences Description and Business Overview

Table 97. Glenmark Life Sciences Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 98. Glenmark Life Sciences Oncology API Product

Table 99. Glenmark Life Sciences Recent Developments/Updates

Table 100. Fresenius Kabi Company Information

Table 101. Fresenius Kabi Description and Business Overview

Table 102. Fresenius Kabi Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 103. Fresenius Kabi Oncology API Product

Table 104. Fresenius Kabi Recent Developments/Updates

Table 105. Sterling Company Information

Table 106. Sterling Description and Business Overview

Table 107. Sterling Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 108. Sterling Oncology API Product

Table 109. Sterling Recent Developments/Updates

Table 110. Mac-Chem Company Information

Table 111. Mac-Chem Description and Business Overview

Table 112. Mac-Chem Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 113. Mac-Chem Oncology API Product

Table 114. Mac-Chem Recent Developments/Updates

Table 115. Biocon Company Information

Table 116. Biocon Description and Business Overview

Table 117. Biocon Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 118. Biocon Oncology API Product

Table 119. Biocon Recent Developments/Updates

Table 120. Olon Company Information

Table 121. Olon Description and Business Overview

Table 122. Olon Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 123. Olon Oncology API Product

Table 124. Olon Recent Developments/Updates

Table 125. Shivalik Rasayan Company Information

Table 126. Shivalik Rasayan Description and Business Overview

Table 127. Shivalik Rasayan Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 128. Shivalik Rasayan Oncology API Product

Table 129. Shivalik Rasayan Recent Developments/Updates

Table 130. Concord Biotech Company Information

Table 131. Concord Biotech Description and Business Overview

Table 132. Concord Biotech Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 133. Concord Biotech Oncology API Product

Table 134. Concord Biotech Recent Developments/Updates

Table 135. Kekulepharma Company Information

Table 136. Kekulepharma Description and Business Overview

Table 137. Kekulepharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 138. Kekulepharma Oncology API Product

Table 139. Kekulepharma Recent Developments/Updates

Table 140. Aenova Company Information

Table 141. Aenova Description and Business Overview

Table 142. Aenova Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 143. Aenova Oncology API Product

Table 144. Aenova Recent Developments/Updates

Table 145. Sarv Biolabs Company Information

Table 146. Sarv Biolabs Description and Business Overview

Table 147. Sarv Biolabs Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 148. Sarv Biolabs Oncology API Product

Table 149. Sarv Biolabs Recent Developments/Updates

Table 150. Aspen Company Information

Table 151. Aspen Description and Business Overview

Table 152. Aspen Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 153. Aspen Oncology API Product

Table 154. Aspen Recent Developments/Updates

Table 155. Suanfarma Company Information

Table 156. Suanfarma Description and Business Overview

Table 157. Suanfarma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 158. Suanfarma Oncology API Product

Table 159. Suanfarma Recent Developments/Updates

Table 160. Bachem Company Information

Table 161. Bachem Description and Business Overview

Table 162. Bachem Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 163. Bachem Oncology API Product

Table 164. Bachem Recent Developments/Updates

Table 165. Piramal Pharma Company Information

Table 166. Piramal Pharma Description and Business Overview

Table 167. Piramal Pharma Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 168. Piramal Pharma Oncology API Product

Table 169. Piramal Pharma Recent Developments/Updates

Table 170. Aurisco Pharmaceutical Company Information

Table 171. Aurisco Pharmaceutical Description and Business Overview

Table 172. Aurisco Pharmaceutical Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 173. Aurisco Pharmaceutical Oncology API Product

Table 174. Aurisco Pharmaceutical Recent Developments/Updates

Table 175. Shilpa Medicare Company Information

Table 176. Shilpa Medicare Description and Business Overview

Table 177. Shilpa Medicare Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 178. Shilpa Medicare Oncology API Product

Table 179. Shilpa Medicare Recent Developments/Updates

Table 180. Qilu Pharmaceutial Company Information

Table 181. Qilu Pharmaceutial Description and Business Overview

Table 182. Qilu Pharmaceutial Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 183. Qilu Pharmaceutial Oncology API Product

Table 184. Qilu Pharmaceutial Recent Developments/Updates

Table 185. Hengrui Company Information

Table 186. Hengrui Description and Business Overview

Table 187. Hengrui Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 188. Hengrui Oncology API Product

Table 189. Hengrui Recent Developments/Updates

Table 190. Hisun Company Information

Table 191. Hisun Description and Business Overview

Table 192. Hisun Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 193. Hisun Oncology API Product

Table 194. Hisun Recent Developments/Updates

Table 195. Zhejiang Xianju Junye Pharmaceutical Company Information

Table 196. Zhejiang Xianju Junye Pharmaceutical Description and Business Overview

Table 197. Zhejiang Xianju Junye Pharmaceutical Oncology API Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)

Table 198. Zhejiang Xianju Junye Pharmaceutical Oncology API Product

Table 199. Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates

Table 200. Key Raw Materials Lists

Table 201. Raw Materials Key Suppliers Lists

Table 202. Oncology API Distributors List

Table 203. Oncology API Customers List

Table 204. Oncology API Market Trends

Table 205. Oncology API Market Drivers

Table 206. Oncology API Market Challenges

Table 207. Oncology API Market Restraints

Table 208. Research Programs/Design for This Report

Table 209. Key Data Information from Secondary Sources

Table 210. Key Data Information from Primary Sources

Table 211. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oncology API

Figure 2. Global Oncology API Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Oncology API Market Share by Type: 2025 & 2032

Figure 4. Alkylating Agents Product Picture

Figure 5. Antimetabolites Product Picture

Figure 6. Others Product Picture

Figure 7. Global Oncology API Market Value by Application (US$ Million), 2021–2032

Figure 8. Global Oncology API Market Share by Application: 2025 & 2032

Figure 9. Chemotherapy

Figure 10. Targeted Therapy

Figure 11. Immunotherapy

Figure 12. Others

Figure 13. Global Oncology API Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Oncology API Market Size (US$ Million), 2021–2032

Figure 15. Global Oncology API Sales (kg), 2021–2032

Figure 16. Global Oncology API Average Price (US$/kg), 2021–2032

Figure 17. Oncology API Report Years Considered

Figure 18. Oncology API Sales Share by Manufacturers in 2025

Figure 19. Global Oncology API Revenue Share by Manufacturers in 2025

Figure 20. Top 5 and Top 10 Global Oncology API Players: Market Share by Revenue in Oncology API in 2025

Figure 21. Oncology API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Global Oncology API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 23. North America Oncology API Sales Market Share by Country (2021–2032)

Figure 24. North America Oncology API Revenue Market Share by Country (2021–2032)

Figure 25. United States Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Canada Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Europe Oncology API Sales Market Share by Country (2021–2032)

Figure 28. Europe Oncology API Revenue Market Share by Country (2021–2032)

Figure 29. Germany Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. France Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. U.K. Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Italy Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Russia Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Asia Pacific Oncology API Sales Market Share by Region (2021–2032)

Figure 35. Asia Pacific Oncology API Revenue Market Share by Region (2021–2032)

Figure 36. China Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Japan Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. South Korea Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. India Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Australia Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. China Taiwan Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Southeast Asia Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Latin America Oncology API Sales Market Share by Country (2021–2032)

Figure 44. Latin America Oncology API Revenue Market Share by Country (2021–2032)

Figure 45. Mexico Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Brazil Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Argentina Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Colombia Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Middle East and Africa Oncology API Sales Market Share by Country (2021–2032)

Figure 50. Middle East and Africa Oncology API Revenue Market Share by Country (2021–2032)

Figure 51. Turkey Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Saudi Arabia Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. UAE Oncology API Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Global Sales Market Share of Oncology API by Type (2021–2032)

Figure 55. Global Revenue Market Share of Oncology API by Type (2021–2032)

Figure 56. Global Oncology API Price (US$/kg) by Type (2021–2032)

Figure 57. Global Sales Market Share of Oncology API by Application (2021–2032)

Figure 58. Global Revenue Market Share of Oncology API by Application (2021–2032)

Figure 59. Global Oncology API Price (US$/kg) by Application (2021–2032)

Figure 60. Oncology API Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Active Pharmaceutical Ingredient API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Niche Active Pharmaceutical Ingredients API and Intermediates Market Research Report 2025

Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Afatinib API Market Research Report 2024

Global NSAID API Market Research Report 2024

Global Ceritinib API Market Research Report 2024

Global Sex Hormone APIs Market Research Report 2024

Global Natural APIs Active Pharmaceutical Ingredients Market Research Report 2024

Active Pharmaceutical Ingredients API CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Niraparib API Market Research Report 2024

Global Highly Potent API HPAPI For Drug conjugates Market Research Report 2025

Global Anastrozole APl Market Research Report 2024

Global Olaparib API Market Research Report 2024

Global Rapamycin API Market Research Report 2025

Global Therapeutic Peptide APIs Market Research Report 2024

Global Biologic Peptide API Market Research Report 2024

Global Crizotinib API Market Research Report 2024

Global Enzymatic Synthesis of Active Pharmaceutical Ingredients APIs Market Research Report 2024

Global Antitumor API Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions